Health ‎Equity

((SLB-058)) (SLB-058) Data Source Selection for Clinical Trial Diversity Planning: Rare Data in Rare Disease

((SLB-059)) (SLB-059) Leveraging Real-World Data to Support Trial Diversity Action Plans – A Fit-for-Purpose Assessment in Waldenström Macroglobulinemia

((SLB-060)) (SLB-060) A Cross-Sectional Study of Race and Ethnicity Reporting and Representation among Cancer Patients in Select US Real-World Data Sources

((SLB-061)) (SLB-061) Racial Disparity in Cardiovascular Outcomes among Older Women with Breast Cancer receiving Anthracycline

((SLB-062)) (SLB-062) Temporal Trends in Racial Differences in Initiation of Medication for Opioid Use Disorder Among Medicaid Beneficiaries

((SLB-063)) (SLB-063) Sex-Related Differences in the Risk of Rehospitalization among Heart Failure Patients in Korea

((SLB-064)) (SLB-064) Risk factors associated with post-COVID-19 condition among 810,851 individuals in Sweden: population-based cohort study

((SLB-065)) (SLB-065) New FDA Guidance On Sex Differences In Post-Marketing Studies: How Much Further Do We Need To Go?

((B-192)) (B-192) Racial and Ethnic Representation in U.S. Based Developmental and Epileptic Encephalopathy Clinical Trials: A Retrospective Analysis

((B-193)) (B-193) Characterizing Latent Tuberculosis and Screening among Individuals diagnosed with Active Tuberculosis Disease in the United States